Patents by Inventor Adam Heller

Adam Heller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220117523
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Application
    Filed: December 27, 2021
    Publication date: April 21, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Publication number: 20220117522
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: November 18, 2021
    Publication date: April 21, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: 11272867
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: March 15, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Publication number: 20220071525
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: November 15, 2021
    Publication date: March 10, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Publication number: 20220000823
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Application
    Filed: September 21, 2021
    Publication date: January 6, 2022
    Inventors: Adam HELLER, Ephraim HELLER, John SPIRIDIGLIOZZI, Steven DIIANNI, Karl Göran WESTERBERG
  • Patent number: 11207005
    Abstract: Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: December 28, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin Jay Feldman, Adam Heller, Namvar Kiaie
  • Publication number: 20210386336
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: August 30, 2021
    Publication date: December 16, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: 11135191
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Grant
    Filed: September 24, 2020
    Date of Patent: October 5, 2021
    Assignee: SynAgile Corporation
    Inventors: Adam Heller, Ephraim Heller, John Spiridigliozzi, Steven Diianni, Evangelos C. Eleftheriou
  • Publication number: 20210267739
    Abstract: The invention features a drug delivery device held in the mouth and continuously administering either a fluid comprising drug dissolved and/or dispersed in water or in a non-toxic liquid, or a drug in solid form.
    Type: Application
    Filed: October 6, 2020
    Publication date: September 2, 2021
    Inventors: Ephraim HELLER, Adam HELLER, Bruce REHLAENDER, John SPIRIDIGLIOZZI
  • Patent number: 11103165
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 31, 2021
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Publication number: 20210204842
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Application
    Filed: March 19, 2021
    Publication date: July 8, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: 10968105
    Abstract: Methods of pyrolytically producing carbons comprising graphene sheets at temperatures below 800° C. are disclosed. The graphene sheets, which are not substantially stacked, are formed by templating on hexagonal metal oxides, for example. Extensive stacking of the graphene sheets, which would lead to formation of graphite, is avoided at the low temperatures employed. Also provided are methods of producing heavily nitrogen doped graphene comprising carbons. Methods of using graphene and heavily nitrogen doped graphene are also disclosed.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: April 6, 2021
    Assignee: Board of Regents, The University of Texas System
    Inventors: Adam Heller, Joo-Woon Lee, David Eisenberg, Keith A. Friedman, Sheryl Coffman
  • Patent number: 10952652
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: March 23, 2021
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Thomas A. Peyser, Adam Heller
  • Publication number: 20210000776
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 7, 2021
    Inventors: Adam HELLER, Ephraim HELLER, Karl Göran WESTERBERG, John SPIRIDIGLIOZZI
  • Patent number: 10786474
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: September 29, 2020
    Assignee: SynAgile Corporation
    Inventors: Adam Heller, John Spiridigliozzi
  • Publication number: 20200299136
    Abstract: Methods of pyrolytically producing carbons comprising graphene sheets at temperatures below 800° C. are disclosed. The graphene sheets, which are not substantially stacked, are formed by templating on hexagonal metal oxides, for example. Extensive stacking of the graphene sheets, which would lead to formation of graphite, is avoided at the low temperatures employed. Also provided are methods of producing heavily nitrogen doped graphene comprising carbons. Methods of using graphene and heavily nitrogen doped graphene are also disclosed.
    Type: Application
    Filed: March 28, 2017
    Publication date: September 24, 2020
    Applicant: Board of Regents, The University of Texas System
    Inventors: Adam Heller, Joo-Woon Lee, David Eisenberg, Keith A. Friedman, Sheryl Coffman
  • Publication number: 20200215012
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 9, 2020
    Inventors: Adam HELLER, Ephraim HELLER, Karl Göran WESTERBERG, John SPIRIDIGLIOZZI
  • Patent number: 10588882
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Grant
    Filed: June 10, 2019
    Date of Patent: March 17, 2020
    Assignee: SynAgile Corporation
    Inventors: Adam Heller, John Spiridigliozzi
  • Publication number: 20190365687
    Abstract: The invention features a pharmaceutical suspension containing drug particles, a drug delivery device anchored in the mouth for continuously administering the pharmaceutical suspension, and methods of their use.
    Type: Application
    Filed: June 10, 2019
    Publication date: December 5, 2019
    Inventors: Adam HELLER, Ephraim HELLER, Karl Göran WESTERBERG, John SPIRIDIGLIOZZI
  • Patent number: 10478108
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: November 19, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Howard Wolpert, Adam Heller